Patent · US Active

Epitopes

US9353174B2 · kind B2 · utility

5Cited by
53References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 20, 2014
Grant dateMay 31, 2016
Priority date—
Expiry dateFeb 20, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.